Campylobacter jejuni: Characteristic Features of the Organism and Identification of Transmissible Plasmids in Tetracycline-Resistant Clinical Isolates

  • Diane E. Taylor


In recent years Campylobacter jejuni has been recognized throughout the world as a common cause of bacterial diarrhea1,2. The organism is microaerophilic, and therefore requires special conditions for selection and growth. Methods developed by Butzler and colleagues3,4 in Belgium and Skirrow5 in the United Kingdom have enabled many microbiological laboratories to isolate this organism from stools and have led to its recognition as a significant enteric pathogen. The relative frequencies of organisms causing gastroenteritis isolated during 1978 and 1979 at the Hospital for Sick Children, Toronto are shown in Table 1. Among pediatric patients reporting with diarrhea, C. jejuni was isolated almost as often as non-typhoidal salmonella. Other enteric pathogens were isolated much less frequently. The most common clinical features of Campylobacter enteritis are diarrhea, often accompanied by blood in the stools, and abdominal pain2. Several excellent review articles have been published recently, dealing with both the disease and the causative organisml,2,6,7,8. The reader is referred to them for more detailed information. In this article, I will describe the significant features of Campylobacters, including their morphology, growth requirements and resistance to antibiotics. I will then discuss recent work on transmissible plasmids that mediate tetracycline resistance in C.jejuni, a preliminary report of which has been published9.


Minimal Inhibitory Concentration Clinical Isolate Nalidixic Acid Sick Child Tetracycline Resistance 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Butzler, J.P. and M.B. Skirrow. Clinics in Gastroenterol. 8: 737–765 (1979).Google Scholar
  2. 2.
    Karmali, M.A. and P.C. Fleming. Can.Med. Assoc. J. 23: 1525–1532 (1979).Google Scholar
  3. 3.
    Butzler, J.P. in: “Modern Topics in Infection”. J.D. Williams ed., pp.214–239. Heinmann, London. (1978).Google Scholar
  4. 4.
    Dekeyser, P., M. Gossuin, M. Detrain, J.P. Butzler and J. Sternon. J. Infect. Dis. 125: 390–392 (1972).PubMedCrossRefGoogle Scholar
  5. 5.
    Skirrow, M.B. British Med. J. ii: 9–11 (1979).Google Scholar
  6. 6.
    Blaser, M.J., I.D. Berkowitz, F.M. LaForce, J. Cravens, L.B. Relier and W.L.L. Wang. Ann. Intern. Med. 91: 179–185 (1979).PubMedGoogle Scholar
  7. 7.
    Sack, R.B., R.C. Tilton, and A.S. Weissfeld. in “Cumulative Techniques and Procedures in Clinical Microbiology” 12, S.J. Rubin ed. pp. 1–13. ASM, Washington, D.C. (1980).Google Scholar
  8. 8.
    Smibert, R.M. Ann. Rev. Microbiol. 32: 673–709 (1978).CrossRefGoogle Scholar
  9. 9.
    Taylor, D.E., S.A. De Grandis, M.A. Karmali and P.C. Fleming. Lancet ii: 797 (1980).CrossRefGoogle Scholar
  10. 10.
    Veron, M. and R. Chatelain. Int. J. Syst. Bacteriol. 23: 122–134 (1973).CrossRefGoogle Scholar
  11. 11.
    Karmali, M.A., A.K. Allen and P.C. Fleming. Int. J. Syst. Bacteriol. (in press-1981).Google Scholar
  12. 12.
    Tiehan, W. and R.L. Vogt. Morbidity Mortality Weekly Rep. 27: 207 (1978).Google Scholar
  13. 13.
    Abbott, J.D., B.A.S. Dale, J. Eldridge, D.M. Jones and E.M. Sutcliffe. J. Clin. Path.33: 762–766 (1980).PubMedCrossRefGoogle Scholar
  14. 14.
    Robinson, D.A., W.J. Edgar, G.L. Gibson, A.A. Matcheff and L. Robertson. British Med. J. 1: 1171–1173 (1979).CrossRefGoogle Scholar
  15. 15.
    Kosunen, T.U., D. Danielsson and J. Kjellander. Acta Path. Microbiol. Scand. Sect. B. 88: 207–218 (1980).Google Scholar
  16. 16.
    Penner, J.L. and J.N. Hennessy. J. Clin. Microbiol, (in press-1980).Google Scholar
  17. 17.
    Ruiz-Palacios, G.M., E. Escamilla and N. Torres. 20th. Interscience Conference on Antimicrobial Agents and Chemotherapy, Abstract 697, ASM, Washington, D.C. (1980).Google Scholar
  18. 18.
    Vanhoof, R., M.P. Vanderlinden, R. Dierickx, S. Lauwers, E. Yourassowsky and J.P. Butzler. Antimicrob. Agents Chemother. 14: 553–556 (1978).PubMedCrossRefGoogle Scholar
  19. 19.
    Karmali, M.A., S. De Grandis and P.C. Fleming. Antimicrob. Agents Chemother, (in press-1981).Google Scholar
  20. 20.
    Brunton, W.A.T., A.M.M. Wilson and R.M. Macrae. Lancet ii: 1385 (1978).CrossRefGoogle Scholar
  21. 21.
    Walder, M. and A. Forsgren. Lancet ii: 1201 (1978).CrossRefGoogle Scholar
  22. 22.
    Vanhoof, R., B. Gordts, R. Dierickx, H. Coigrau, and J.P. Butzler. Antimicrob. Agents Chemother. 18: 118–121 (1980).PubMedCrossRefGoogle Scholar
  23. 23.
    Walder, M. Antimicrob. Agents Chemother. 16: 37–39 (1979).PubMedCrossRefGoogle Scholar
  24. 24.
    Austen, R.A., and Trust, T.J. FEMS Microbiological Letters 8: 201–204 (1980).CrossRefGoogle Scholar
  25. 25.
    Taylor, D.E., and R.B. Grant. Molec. Gen. Genet. 153: 5–10 (1977).PubMedCrossRefGoogle Scholar
  26. 26.
    Meyers, J.A., D. Sanchez, L.P. Elwell and S. Falkow. J. Bacteriol. 127: 1529–1537 (1976).PubMedGoogle Scholar
  27. 27.
    Taylor, D.E. and J.G. Levine. J. Gen. Microbiol. 116: 475–484 (1980).PubMedGoogle Scholar
  28. 28.
    Bradley, D.E., D.E. Taylor and D.R. Cohen. J. Bacteriol. 143: 1466–1470 (1980).PubMedGoogle Scholar
  29. 29.
    Shahrabadi, M.S., L.E. Bryan and H.M. Van Den Elzen. Can. J. Microbiol. 21: 592–605 (1975).PubMedCrossRefGoogle Scholar
  30. 30.
    Welch, R.A., K.R. Jones and F.L. Macrina. Plasmid 2: 261–268 (1979).PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1981

Authors and Affiliations

  • Diane E. Taylor
    • 1
  1. 1.Research Institute and Department of BacteriologyThe Hospital for Sick ChildrenTorontoCanada

Personalised recommendations